Pulseline

17th May 2017

What's New?

 

MedTech industry welcomes balanced Prostheses List Report
MTAA has welcomed the findings of the Senate Inquiry into the price regulation associated with the Prostheses List Framework. 

 

The Senate Committee report clearly reflected the complexity of the issues involved in medical device pricing and rejected the slash and burn approach advocated by the private health insurers.  The recommendations of the report are sensible and MTAA supports them.

 

Therapeutic Development a key focus of the Roadmap

MTAA welcomes the 2016 National Research Infrastructure Roadmap and its recommendations, in particular around the need to increase capacity to develop new therapies or medical devices.

 

Clinical Trials 2017: National Tribute & Awards Ceremony

MTAA is supporting the Clinical Trials 2017: National Tribute & Awards Ceremony on Friday 19th May, 2017.  This event coincides with International Clinical Trials Day, raising the public awareness of clinical trials and honours clinical research professionals for their contribution to public health and medical progress.

 
Image

MedTech 2017 Annual Conference
The MTAA MedTech 2017 Annual Conference will be held on 1-2 November 2017 at Doltone House, Jones Bay Wharf, Sydney. The theme for this year is "The Value of Medical Technology to a Healthier Australia"


Registration for MTAA MedTech 2017 Annual Conference will open soon.

 

Industry News

 

Review of the MedTech Forum: The Clinical Research Landscape

100 of the brightest minds from MedTech, healthcare, government and beyond, 12 pre-eminent speakers, and 1 successful event: Medtronic’s modern North Ryde headquarters on Thursday played host to this year’s MedTech Forum.

 
Image

Interview with Professor Tony Weiss

Professor Weiss is a rare blend of successful Australian academic researcher, innovator and company Scientific Founder of Elastagen Pty Ltd.

 

He was one of the speakers at the MedTech Forum: Australian MedTech Innovation - The Clinical Research Landscape on Thursday 11th May. He was interviewed by Amanda Ogilvie from the Australian Chamber of Commerce & Industry (ACCI) as part of the Biz Better Together initiative.

 
Image

WHO list of priority medical devices for cancer management

The World Health Organisation (WHO) Priority medical devices for cancer care was launched in the 3rd Global Forum on medical devices in Geneva, last Friday 12th of May. This publication addresses medical devices based on the list of clinical interventions selected from clinical guidelines on prevention, screening, diagnosis, treatment, palliative care, monitoring and end of life care. 

 
 

External Opportunities

 

Is your career in the best of health?

Earn your Graduate Certificate in Regulatory Science online

Developed by industry experts, the University of Wollongong Graduate Certificate in Regulatory Science is a 12-month, online course that will give you the qualification you need to become a regulatory affairs specialist.  It’s the perfect health-kick for:

  • Your career This course is perfect for those who want to broaden their scope for employment and gain the knowledge to advance and future-proof their regulatory affairs career.
  • Public health By focusing on the entire product life cycle, this course will equip you with the skills to protect the health of the public, bring new products to market faster, and more efficiently managing regulatory affairs.
  • The business Help navigate the complex regulatory environment to improve investment outcomes for your business by learning a quality management system approach to managing regulatory compliance.


Applications are now open. Course starts 24 July.

 
Latest Pulseline Newsletter
 
Twitter
 
LinkedIn
 
Web Site
 

P (+612) 9900 0600

F (+612) 9900 0655

E mtaa@mtaa.org.au

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.


© 2017 Medical Technology Association of Australia, All rights reserved.
This e-mail is for the use of the intended recipient(s) only. If you have received this e-mail in error, please notify the sender immediately and then delete it. If you are not the intended recipient, you must not use, disclose or distribute this e-mail without the author's permission.